NCT07375121

Brief Summary

Perioperative pain management affects patient recovery. However, the rate of moderate to severe postoperative pain is as high as 73.8%, which hinders recovery and increases the risk of complications. Although opioids are the first-line analgesics, excessive use leads to adverse reactions. The traditional fixed-rate PCA mode is difficult to match the changes in postoperative pain. This study will compare different PCA mode optimization strategies, assuming that they can reduce opioid dosage, improve analgesic effect, and reduce adverse reactions, providing high-quality evidence-based basis for postoperative analgesia and promoting individualized and intelligent management.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for not_applicable surgery

Timeline
8mo left

Started Dec 2025

Shorter than P25 for not_applicable surgery

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Dec 2025Dec 2026

Study Start

First participant enrolled

December 30, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

January 13, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 29, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

10 months

First QC Date

January 13, 2026

Last Update Submit

January 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cumulative opioid consumption

    Within the first 24 hours postoperatively

Secondary Outcomes (9)

  • Resting and movement pain score was assessed by numeric rating scale.

    At 1, 6, 12, 24, and 48 hours postoperatively

  • Cumulative patient-controlled analgesia volume consumption

    Within the first 24 hours postoperatively

  • Frequency of additional rescue analgesics

    At 12, 24, and 48 hours postoperatively

  • Dosage of additional rescue analgesics

    At 12, 24, and 48 hours postoperatively

  • Postoperative quality of recovery

    At 24, and 48 hours postoperatively

  • +4 more secondary outcomes

Study Arms (2)

Fixed-rate basal infusion mode group

ACTIVE COMPARATOR
Procedure: Fixed-rate basal infusion mode

time-programmed decremental background infusion mode group

EXPERIMENTAL
Procedure: Time-programmed decremental background infusion mode

Interventions

All participants received a standardized PCA solution containing sufentanil (100 μg), ondansetron (16 mg), and normal saline with total volume 100 mL. In conventional fixed-rate basal infusion mode group, the PCA was set to administer a bolus of 2 mL with a lock out interval of 15 minutes and background infusion rate 2 mL/h.

Fixed-rate basal infusion mode group

The PCA settings were based on the previous study. The rate, loading dose, and demand dose of the PCA pump were all calculated based on lean body weight: Lean body weight (kg) = 0.29569 \* body weight (kg) + 0.41813 \* height (cm) - 43.2933. Loading dose (mL) = lean body weight (kg) \* 0.1 mL. Demand dose (mL) = lean body weight (kg) \* 0.04 mL. Background infusion rate within 6 hours after surgery (mL/h) = lean body weight (kg) \* 0.1 mL/h. Background infusion rate from 6 to 24 hours after surgery (mL/h) = lean body weight (kg) \* 0.02 mL/h. Background infusion rate from 24 to 48 hours after surgery (mL/h) = lean body weight (kg) \* 0.01 mL/h.

time-programmed decremental background infusion mode group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged between 18 to 65 years;
  • American Society of Anesthesiologists physical status Ⅰ - Ⅲ;
  • Patients scheduled for elective mixed surgery were enrolled. Mixed surgeries included thoracoscopic surgery, laparoscopic surgery, hysteroscopy surgery, laparotomy, thoracotomy, open spinal surgery, craniotomy, and so on.

You may not qualify if:

  • Chronic pain syndromes;
  • Psychiatric disorders;
  • Severe cardiovascular or cerebrovascular disease, renal or hepatic functional dysfunction, or allergic to PCA medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital, Beijing, Beijing 100070

Beijing, China

RECRUITING

Related Links

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Department of Pain Management, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

January 13, 2026

First Posted

January 29, 2026

Study Start

December 30, 2025

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

January 29, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures and appendices) are available. Derived data supporting the findings of this study are available from the corresponding author Fang Luo on request.

Locations